Auricular acupressure improves sleep quality in pregnant women with insomnia
In a randomized, double-blind trial of 86 pregnant women (≥28 weeks' gestation) with insomnia, auricular acupressure (AA) significantly reduced Pittsburgh Sleep Quality Index (PSQI) scores by 3.51 points (p < 0.01) and increased nightly sleep duration (p < 0.01) compared to sham AA. No adverse events occurred, indicating AA is a safe and effective non-invasive intervention for insomnia during pregnancy.
Evidence Score
Study Evidence
Study 1. Efficacy of auricular acupressure for insomnia in pregnant women: A randomized, double-blind, controlled trial.
observationalXu X, Lv M, Zhang W, Wu X, Mi Z, Xu W, Xu L, Dong W, Wu Y, Chen L, Luo Q · Explore (New York, N.Y.) (2026)
Result:
Mechanism Graph
Limitations
- ⚠High dropout rate (9 out of 86 participants did not complete the trial)
- ⚠Single study with relatively small sample size (77 completers)
Frequently Asked Questions
What is auricular acupressure?▼
Auricular acupressure is a non-invasive technique that involves applying pressure to specific points on the ear to stimulate healing and relieve symptoms, such as insomnia.
Is auricular acupressure safe during pregnancy?▼
Yes, this study reported no adverse events in either the AA or sham AA group, suggesting it is safe for pregnant women with insomnia.
How much did sleep quality improve in the AA group?▼
The AA group showed a significant reduction in PSQI score by 3.51 points (p < 0.01) and increased nightly sleep duration compared to the sham group.
Does auricular acupressure affect mental health in pregnant women?▼
Yes, the study found that AA was associated with reduced depressive and anxiety symptoms and improved diurnal cortisol rhythms.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Xu X, Lv M, Zhang W, Wu X, Mi Z, Xu W, Xu L, Dong W, Wu Y, Chen L, Luo Q. "Efficacy of auricular acupressure for insomnia in pregnant women: A randomized, double-blind, controlled trial.." Explore (New York, N.Y.), 2026. PMID: 42508202 DOI: 10.1016/j.explore.2026.103502